Investigation of Susceptibility of Influenza Viruses A (H1N1), the Cause of Infection in Humans in April - May 2009, to Antivirals in MDCK Cell Culture

Biological properties of influenza viruses A (H1N1), that were the cause of the infection in humans in April - May 2009, and the action of the Russian antivirals on their reproduction were studied in vitro. The nucleotide sequence in the viruses was determined and followed by detection of the mutations responsible for resistance to the antiinfluenza drugs. The experiments showned that arbidol and ribavirin had a selective inhibitory action on reproduction of the viruses in the MDCK cell culture while rimantadine had no affect on their reproduction. The data were confirmed by the results of the genome analysis in influenza viruses A/California/04/2009(H1N1), A/California/07/2009(H1N1) and A/Moscow/01/2009(H1N1)swl, that revealed no replacements defining the resistance to arbidol while the viruses contained a mutation in position 31 of М2 protein, responsible for the resistance to adamantans.

influenza virus A (H1N1), arbidol, ribavirin, rimantadine, virus inhibition activity, cell culture

1. Emergence of novel swine-origin influenza A (H1N1) virus in human. Novel swine-origin influenza A (H1N1) virus investigation team. The New England Journal of Medicine 2009; 10: 1-10.

2. FDA. Antiviral Drug Advisory Committee. Gaithersburg: Centre for Drug Evaluation and Research 2002; 1-266.

3. Zlydnikov D. M., Kubar O. I., Kovaleva T. P. et al. Study of rimantadine in the USSR: a review of the literature. Rev Infect Dis 1981; 3: 408-421.

4. Hayden F. WHO guidelines on the use of vaccines and antivirals during influenza. Annex 5-considerations for the use of antivirals during an influenza pandemic, Geneva, 2-4 October, 2002.

5. Glushkov R. G. Arbidol. Antiviral, immunostimulant, interferon inducer. Drug Future 1992; 17: 1079-1081.

6. Гуськова Т. А., Глушков P. Г. Арбидол - иммуномодулятор, индуктор интерферона, антиоксидант. М.: 1999; 93.

7. Rodriguez W. J., Hall C. B., Welliver R. et al. Efficacy and safety of aerosolized ribavirin in young children hospitalized with influenza: a double-blind, multicenter, placebo-controlled trial. J Pediatr 1994; 125: 129-35.

8. MMWR Morb Mortal Wkly Rep. Update: drug susceptibility of swineorigin influenza A (H1N1) viruses, April 2009.Centers for Disease Control and Prevention (CDC) 2009; 58: 433-435.

9. Meguro, H., Bryant, J. D., Torrence, A. E.,Wright, P. F. Canine kidney cell line for isolation of respiratory viruses. J Clin Microbiol 1979; 9: 175-179.

10. Ашмарин И. П., Воробьев А. А. Статистические методы в микробиологических исследованиях. Л.: 1962; 173.

11. Ленёва И. А., Фадеева Н. И., Федякина И. Т. и др. Применение иммуноферментной индикации вирусспецифических антигенов в изучении нового противогриппозного препарата арбидола. ХФЖ 1994; 9: 4-8.

12. Gambaryan A. S., Tuzikov A. B., Piskarev V. E. et al. Specification of receptor-binding phenotypes of influenza virus isolates from different hosts using synthetic sialylglycopolimers non-egg-adapted human H1 and H3 influenza A and influenza B viruses share a common high binding affinity for 6'sialyl(N-acetyllactosamine). Virology 1997; 232: 345-350.

13. Ward A. Virulence of influenza A virus for mouse lung. Virus Genes 1997; 14: 187-194.

14. Hay A. Amantadine and Rimantadine Mechanisms. In book: Antiviral Drug Resistance, D.Richman (ed), John Willey and Sons Ltd, UK. 1996; 44-58.

15. Monto A. Viral susceptibility and the choice of influenza antivirals. Clinical Infectious Diseases 2008; 47: 346-348.

16. Leneva I. A., Russell R. J., Boriskin Y. S., Hay A. J. Characteristics of arbidol-resistant mutants of influenza virus: implications for the mechanism of anti-influenza action of arbidol. Antiviral Res 2009.

17. Avian influenza A (H5N1) infection in humans. The writing Committee of the WHO Consultation on human influenza A/H5. New Engl J Med 2005; 353: 1374-1385.

18. Ленева И. А., Федякина И. Т., Гуськова Т. А., Глушков Р. Г. Чувствительность различных штаммов вируса гриппа к арбидолу. Изучение эффекта арбидола на репродукцию вируса гриппа А в комбинации с различными противовирусными препаратами Тер архив 2005; 8: 84-88.

19. Crotty S., Cameron C., Andino R. Ribavirin's antiviral mechanism of action: lethal mutagenesis? J Med Chem. 2002; 80: 86-95.